Genetic variations in regulatory pathways of fatty acid and glucose metabolism are associated with obesity phenotypes: A population-based cohort study

International Journal of Obesity

Volumn 33, Issue 10, 2009, Pages 1143-1152

  Van Den Berg, S W ^a   Dolle M E T ^a   Imholz, S ^a   Van Der A, D L ^a   Van T Slot, R ^b   Wijmenga, C ^b,c   Verschuren, W M M ^a   Strien, C ^a   Siezen, C L E ^a   Hoebee, B ^a   Feskens, E J M ^d   Boer, J M A ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

BMI; Cohort; GATA; NR1H4; SNP; WAIST

Indexed keywords

FARNESOID X RECEPTOR; FATTY ACID; GLUCOSE; INTERLEUKIN 6; CELL RECEPTOR; FARNESOID X-ACTIVATED RECEPTOR; INTERLEUKIN 16; MEMBRANE PROTEIN; SIGNAL PEPTIDE; SIRT1 PROTEIN, HUMAN; SIRTUIN 1; SMARCA2 PROTEIN, HUMAN; SREBP CLEAVAGE-ACTIVATING PROTEIN; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; FATTY ACID METABOLISM; FEMALE; GENE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; NR1H4 GENE; OBESITY; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; SCAP GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SIRT1 GENE; SMARCA2 GENE; WAIST CIRCUMFERENCE; COHORT ANALYSIS; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; NETHERLANDS; YOUNG ADULT;

ADULT; BODY MASS INDEX; COHORT STUDIES; FATTY ACIDS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GLUCOSE; HUMANS; INTERLEUKIN-16; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NETHERLANDS; OBESITY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIRTUIN 1; TRANSCRIPTION FACTORS; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 70349974821     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2009.152     Document Type: Article

References (58)

1. World Health Organization. Fact sheet N 311 Obesity and overweight. Http://Www.Who.Int/Mediacentre/Factsheets/Fs311/En/Index.Html 2006.
2. Wang Y, Lobstein T. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes 2006; 1: 11-25.
3. Kopelman PG. Obesity as a medical problem. Nature 2000; 404: 635-643.
4. Anandacoomarasamy A, Caterson I, Sambrook P, Fransen M, March L. The impact of obesity on the musculoskeletal system. Int J Obes 2008; 32: 211-222.
5. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3: e442.
6. Yang W, Kelly T, He J. Genetic epidemiology of obesity. Epidemiol Rev 2007; 29: 49-61.
7. Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. BMJ 1995; 311: 158-161.
8. Rankinen T, Zuberi A, Chagnon YC, Weisnagel SJ, Argyropoulos G, Walts B. et al. The human obesity gene map: the 2005 update. Obesity 2006; 14: 529-644.
9. Loos RJ, Bouchard C. ObesityFis it a genetic disorder? J Intern Med 2003; 254: 401-425.
10. Bell CG, Walley AJ, Froguel P. The genetics of human obesity. Nat Rev Genet 2005; 6: 221-234.
11. Hunt MS, Katzmarzyk PT, Perusse L, Rice T, Rao DC, Bouchard C. Familial resemblance of 7-year changes in body mass and adiposity. Obes Res 2002; 10: 507-517.
12. Tonjes A, Scholz M, Loeffler M, Stumvoll M. Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals. Diabetes Care 2006; 29: 2489-2497.
13. Young EH, Wareham NJ, Farooqi S, Hinney A, Hebebrand J, Scherag A et al. The V103I polymorphism of the MC4R gene and obesity: population based studies and meta-analysis of 29 563 individuals. Int J Obes 2007; 31: 1437-1441.
14. Sookoian SC, Gonzalez C, Pirola CJ. Meta-analysis on the G-308A tumor necrosis factor alpha gene variant and phenotypes associated with the metabolic syndrome. Obes Res 2005; 13: 2122-2131.
15. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007; 316: 889-894.
16. Benzinou M, Creemers JW, Choquet H, Lobbens S, Dina C, Durand E et al. Common nonsynonymous variants in PCSK1 confer risk of obesity. Nat Genet 2008; 40: 943-945.
17. Hattersley AT, McCarthy MI. What makes a good genetic association study? Lancet 2005; 366: 1315-1323.
18. Marvelle AF, Lange LA, Qin L, Adair LS, Mohlke KL. Association of FTO with obesity-related traits in the Cebu Longitudinal Health and Nutrition Survey (CLHNS) Cohort. Diabetes 2008; 57: 1987-1991.
19. Dolley G, Bertrais S, Frochot V, Bebel JF, Guerre-Millo M, Tores F et al. Promoter adiponectin polymorphisms and waist/hip ratio variation in a prospective French adults study. Int J Obes 2008; 32: 669-675.
20. Snieder H, Wang X, Shiri-Sverdlov R, van Vliet-Ostaptchouk JV, Hofker MH, Perks U et al. TUB is a candidate gene for late-onset obesity in women. Diabetologia 2008; 51: 54-61.
21. Herbert A, Gerry NP, McQueen MB, Heid IM, Pfeufer A, Illig T et al. A common genetic variant is associated with adult and childhood obesity. Science 2006; 312: 279-283.
22. Liu YJ, Liu XG, Wang L, Dina C, Yan H, Liu JF et al. Genome-wide association scans identified CTNNBL1 as a novel gene for obesity. Hum Mol Genet 2008; 17: 1803-1813.
23. Loos RJ, Lindgren CM, Li S, Wheeler E, Zhao JH, Prokopenko I et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 2008; 40: 768-775.
24. Sorensen TI, Boutin P, Taylor MA, Larsen LH, Verdich C, Petersen L et al. Genetic polymorphisms and weight loss in obesity: a randomised trial of hypo-energetic high-versus low-fat diets. PLoS Clin Trials 2006; 1: e12.
25. Desvergne B, Michalik L, Wahli W. Transcriptional regulation of metabolism. Physiol Rev 2006; 86: 465-514.
26. Verschuren WMM, Blokstra A, Picavet HSJ, Smit HA. Cohort profile: the Doetinchem Cohort Study. Int J Epidemiol 2008; 37: 1236-1241.
27. World Health Organisation. Measuring ObesityFClassification and Description of Anthropometric Data. Regional Office for Europe. EUR/ICP/NUT 125, 1989.
28. Hoebee B, Rietveld E, Bont L, Oosten M, Hodemaekers HM, Nagelkerke NJ et al. Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms. J Infect Dis 2003; 187: 2-11.
29. Becker KG, Barnes KC, Bright TJ, Wang SA. The genetic association database. Nat Genet 2004; 36: 431-432.
30. Riva A, Kohane IS. A SNP-centric database for the investigation of the human genome. BMC Bioinformatics 2004; 5: 33.
31. Xu H, Gregory SG, Hauser ER, Stenger JE, Pericak-Vance MA, Vance JM et al. SNPselector: a web tool for selecting SNPs for genetic association studies. Bioinformatics 2005; 21: 4181-4186.
32. Fan JB, Chee MS, Gunderson KL. Highly parallel genomic assays. Nat Rev Genet 2006; 7: 632-644.
33. Twisk JWR. Applied Longitudinal Data Analysis for Epidemiology, A Practical Guide. Press Syndicate of the University of Cambridge: Cambridge, 2003.
34. Benjamini Y, Yekutieli D. Quantitative trait Loci analysis using the false discovery rate. Genetics 2005; 171: 783-790.
35. Allison DB, Cui X, Page GP, Sabripour M. Microarray data analysis: from disarray to consolidation and consensus. Nat Rev Genet 2006; 7: 55-65.
36. Smith NL, Hindorff LA, Heckbert SR, Lemaitre RN, Marciante KD, Rice K et al. Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. JAMA 2007; 297: 489-498.
37. Wang B, Zhao H, Zhou L, Dai X, Wang D, Cao J et al. Association of genetic variation in apolipoprotein E and low density lipoprotein receptor with ischemic stroke in Northern Han Chinese. J Neurol Sci 2009; 276: 118-122.
38. Ferrari SL, Ahn-Luong L, Garnero P, Humphries SE, Greenspan SL. Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab 2003; 88: 255-259.
39. Cancello R, Tounian A, Poitou Ch, Clement K. Adiposity signals, genetic and body weight regulation in humans. Diabetes Metab 2004; 30: 215-227.
40. Slattery ML, Curtin K, Sweeney C, Wolff RK, Baumgartner RN, Baumgartner KB et al. Modifying effects of IL-6 polymorphisms on body size-associated breast cancer risk. Obesity 2008; 16: 339-347.
41. Hamid YH, Rose CS, Urhammer SA, Glumer C, Nolsoe R, Kristiansen OP et al. Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes. Diabetologia 2005; 48: 251-260.
42. Qi L, Zhang C, van Dam RM, Hu FB. Interleukin-6 genetic variability and adiposity: associations in two prospective cohorts and systematic review in 26,944 individuals. J Clin Endocrinol Metab 2007; 92: 3618-3625.
43. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007; 316: 1331-1336.
44. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005; 434: 113-118.
45. Fox CS, Heard-Costa N, Cupples LA, Dupuis J, Vasan RS, Atwood LD. Genome-wide association to body mass index and waist circumference: the Framingham Heart Study 100K project. BMC Med Genet 2007; 8(Suppl 1): S18.
46. Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 2006; 439: 484-489.
47. Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002; 109: 1125-1131.
48. Le Hellard S, Theisen FM, Haberhausen M, Raeder MB, Ferno J, Gebhardt S et al. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects? Mol Psychiatry 2008; 14: 308-317.
49. Nieminen T, Matinheikki J, Nenonen A, Kukkonen-Harjula K, Lindi V, Hamelahti P et al. The relationship of sterol regulatory element-binding protein cleavage-activation protein and apoli-poprotein E gene polymorphisms with metabolic changes during weight reduction. Metabolism 2007; 56: 876-880.
50. Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell 1995; 83: 841-850.
51. Xu L, Glass CK, Rosenfeld MG. Coactivator and corepressor complexes in nuclear receptor function. Curr Opin Genet Dev 1999; 9: 140-147.
52. Muchardt C, Yaniv M. ATP-dependent chromatin remodelling: SWI/SNF and Co. are on the job. J Mol Biol 1999; 293: 187-198.
53. Fischle W, Dequiedt F, Hendzel MJ, Guenther MG, Lazar MA, Voelter Wet al. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol Cell 2002; 9: 45-57.
54. Xu J, Li Q. Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol Endocrinol 2003; 17: 1681-1692.
55. Misra P, Qi C, Yu S, Shah SH, Cao WQ, Rao MS et al. Interaction of PIMT with transcriptional coactivators CBP, p300, and PBP differential role in transcriptional regulation. J Biol Chem 2002; 277: 20011-20019.
56. Puigserver P, Spiegelman BM. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcrip-tional coactivator and metabolic regulator. Endocr Rev 2003; 24: 78-90.
57. Oishi Y, Manabe I, Tobe K, Ohsugi M, Kubota T, Fujiu K et al. SUMOylation of Kruppel-like transcription factor 5 acts as a molecular switch in transcriptional programs of lipid metabolism involving PPAR-delta. Nat Med 2008; 14: 656-666.
58. Tong Q, Tsai J, Tan G, Dalgin G, Hotamisligil GS. Interaction between GATA and the C/EBP family of transcription factors is critical in GATA-mediated suppression of adipocyte differentiation. Mol Cell Biol 2005; 25: 706-715.